张莉，研究员，博士生导师。本科毕业于中山大学公共卫生学院预防医学专业，博士毕业于老虎机游戏流行病与卫生统计专业。曾获WHO/IARC博士后奖学金、2020年国际乳头瘤病毒大会会议奖学金、2018年亚洲及太平洋癌症预防组织大会最佳口头报告奖、2018年中国肿瘤学大会中青年优秀论文三等奖、2017国际乳头瘤病毒大会会议奖学金。
     老虎机游戏引进人才，2023年加入老虎机游戏。曾于2019年11月-2022年12月在世界卫生组织/国际癌症研究署（WHO/IARC）从事博士后研究员工作。

依托国内以人群为基础的肿瘤筛查长期随访队列和国际肿瘤筛查实施评估平台，在常见恶性肿瘤的筛查方案优化、组织实施评估、国际专家共识等领域开展了一系列研究，研究成果被国际权威手册/指南引用，并多次获得国际会议的会议奖学金资助。以第一作者身份在 Nature Medicine，EClinicalMedicine，BMC Medicine 等杂志发表论文十余篇，主持医科院创新工程、世界卫生组织/国际癌症研究署（WHO/IARC）博士后归国基金、国家自然科学基金、科技部海外博士后引才项目等研究。

老虎机游戏

1. Zhong P, Zhang L*, Zhao F*. Modeling cervical cancer elimination: a pathway to inform policy decisions. Cancer Biol Med. 2025 Oct 6;22(9):1002–9.

2. Han J^#, Zhang L^#, Chen Y^#, Zhang Y, Wang L, Cai R, Li M, Dai Y, Dang L, Chen H*, Zhu L*. Global HPV vaccination programs and coverage rates: a systematic review. EClinicalMedicine. 2025 Jun 9;84:103290.

3. Li Zhang#, Isabel Mosquera, Eric Lucas, Mary Luz Rol, Andre L. Carvalho, Partha Basu*, CanScreen5 collaborators. Organisation and implementation of breast, cervical and colorectal cancer screening programmes from 84 countries: the CanScreen5 global repository, Nature Medicine, 2023;29(5):1135-1145.

4. Li Zhang#, Catherine Sauvaget, Isabel Mosquera, Partha Basu*. Efficacy, acceptability and safety of ablative vs excisional procedure in the treatment of histologically confirmed CIN2-3: a systematic review. BJOG. 2023;130(2):153-61.

5. Li Zhang#, André L Carvalho, Isabel Mosquera, Tianmeng Wen, Eric Lucas, Catherine Sauvaget, Richard Muwonge, Marc Arbyn, Elisabete Weiderpass, Partha Basu*. An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme. BMC Med. 2022,23;20(1):101. (R)

6. Li Zhang#, Xuelian Zhao, Shangying Hu, Shimin Chen, Shuang Zhao, Li Dong, André L Carvalho, Richard Muwonge, Fanghui Zhao*, Partha Basu. Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study. Int J Cancer.2022;151(6):878-87.

7. Mengmeng Li#*, Li Zhang#, Hadrien Charvat*, Matthew E. Callister, Peter Sasieni, Evangelia Christodoulou, Rudolf Kaaks, Mattias Johansson, Andre L. Carvalho, Salvatore Vaccarella, Hilary A. Robbins*. The influence of post-screening follow-up time and other factors on estimates of overdiagnosis from lung cancer screening trials. Int J Cancer. 2022;151(9):1491-501.